Edit |   |
---|---|
Antigenic Specificity | TYRP1, Human (Flanvotumab biosimilar) |
Clone | Flanvotumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | ELISA, FCM, IP, FuncS, IF, Neut, ICC |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human TYRP1 Recombinant Antibody. Flanvotumab, also known as IMC-20D7S, is a human monoclonal antibody designed for the treatment of melanoma. It targets TYRP1. Flanvotumab was developed by ImClone Systems, now owned by Eli Lilly. |
Immunogen | n/a |
Other Names | Anti-TYRP1 Recombinant Antibody, Research Grade Flanvotumab, Anti-Human TYRP1 Recombinant Antibody, 20D7S, IMC-20D7S, Antibody Drug Analogues, Monoclonal Antibody, YR1267, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1188277-05-5 |
Catalog # | YR1267 |
Price | please inquire |
Order / More Info | TYRP1, Human (Flanvotumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |